SEC-sourced researchBeta
CPMD
CANNAPHARMARX, INC.
Company comparison ↗
Data passport
- CIK
- 0001081938
- Exchange
- OTC
- Business activity
- — · SIC 2834
- Financial inputs
- 6/6
- Filing date
- Mar 31, 2026
- SEC registry record
- Operating company
Annual financial history
Up to three published annual periods. The chart shows financial statement amounts; missing observations are not connected. Each company chart uses its own scale; compare amounts in the table.
| Period end | Revenue | Filing date |
|---|---|---|
| December 2024 | 820,137.0000 | Mar 31, 2026 |
| December 2025 | 1,362,163.0000 | Mar 31, 2026 |
Annual periods · USD
| Period end | Revenue | Net income | Operating cash flow | Total assets | Total liabilities | Filing date |
|---|---|---|---|---|---|---|
| December 2025 | 1,362,163.0000 | -11,131,448.0000 | -789,102.0000 | 7,018,404.0000 | 37,172,133.0000 | Mar 31, 2026 |
| December 2024 | 820,137.0000 | -9,905,789.0000 | -1,697,232.0000 | 10,835,697.0000 | 30,645,334.0000 | Mar 31, 2026 |
Financial inputs behind the calculation
| Financial inputs | USD | Period end | Filing date | Form |
|---|---|---|---|---|
| RevenueRevenues | $1.36M | December 2025 | Mar 31, 2026 | 10-K |
| Previous period revenueRevenues | $820.14K | December 2024 | Mar 31, 2026 | 10-K |
| Net incomeNetIncomeLoss | -$11.13M | December 2025 | Mar 31, 2026 | 10-K |
| Operating cash flowNetCashProvidedByUsedInOperatingActivities | -$789.1K | December 2025 | Mar 31, 2026 | 10-K |
| Total assetsAssets | $7.02M | December 2025 | Mar 31, 2026 | 10-K |
| Total liabilitiesLiabilities | $37.17M | December 2025 | Mar 31, 2026 | 10-K |